Literature DB >> 16790910

Brachytherapy technology and physics practice since 1950: a half-century of progress.

Jeffrey F Williamson1.   

Abstract

The 50-year tenure of Physics in Medicine and Biology has coincided with some of the most important developments in radiological science, including the introduction of artificial radioactivity, computers and 3D imaging into medicine. These events have profoundly influenced the development of brachytherapy. Although it is not the dominant radiotherapy modality, it continues to play an important role in cancer therapy, more than a century after its introduction. This paper reviews the impact of three broad categories of innovation introduced since 1950 from the North American perspective: the introduction of artificial radioactivity, computer- and image-based treatment planning, and basic single-source dosimetry.

Entities:  

Mesh:

Year:  2006        PMID: 16790910     DOI: 10.1088/0031-9155/51/13/R18

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  12 in total

1.  BJR brachytherapy dosimetry special feature.

Authors:  A L Palmer
Journal:  Br J Radiol       Date:  2014-07-23       Impact factor: 3.039

2.  3D-CT implanted interstitial brachytherapy for T2b nasopharyngeal carcinoma.

Authors:  Yu-Feng Ren; Yuan-Hong Gao; Xin-Ping Cao; Wei-Jun Ye; Bin S Teh
Journal:  Radiat Oncol       Date:  2010-11-23       Impact factor: 3.481

3.  CT-guidance interstitial (125)Iodine seed brachytherapy as a salvage therapy for recurrent spinal primary tumors.

Authors:  Qianqian Cao; Hao Wang; Na Meng; Yuliang Jiang; Ping Jiang; Yang Gao; Suqing Tian; Chen Liu; Ruijie Yang; Junjie Wang; Kaixian Zhang
Journal:  Radiat Oncol       Date:  2014-12-23       Impact factor: 3.481

4.  Establishment of air kerma reference standard for low dose rate Cs-137 brachytherapy sources.

Authors:  Sunil Dutt Sharma; Sudhir Kumar; P Srinivasan; G Chourasiya
Journal:  J Appl Clin Med Phys       Date:  2011-11-15       Impact factor: 2.102

5.  Stenting of the Portal Vein Combined with Different Numbers of Iodine-125 Seed Strands: Dosimetric Analyses.

Authors:  Li-Hong Yao; Liang Su; Lu Liu; Hai-Tao Sun; Jun-Jie Wang
Journal:  Chin Med J (Engl)       Date:  2017-09-20       Impact factor: 2.628

6.  A Novel Computer-Aided Diagnosis Scheme on Small Annotated Set: G2C-CAD.

Authors:  Guangyuan Zheng; Guanghui Han; Nouman Q Soomro; Linjuan Ma; Fuquan Zhang; Yanfeng Zhao; Xinming Zhao; Chunwu Zhou
Journal:  Biomed Res Int       Date:  2019-04-15       Impact factor: 3.411

7.  Comparison of (60)Co and (192)Ir sources in HDR brachytherapy.

Authors:  Stefan Strohmaier; Grzegorz Zwierzchowski
Journal:  J Contemp Brachytherapy       Date:  2011-12-30

8.  Local tumor control probability to evaluate an applicator-guided volumetric-modulated arc therapy solution as alternative of 3D brachytherapy for the treatment of the vaginal vault in patients affected by gynecological cancer.

Authors:  Piernicola Pedicini; Lidia Strigari; Rocchina Caivano; Alba Fiorentino; Giorgia Califano; Antonio Nappi; Giuseppina Improta; Giovanni Storto; Mariella Cozzolino; Costanza Chiumento; Vincenzo Fusco; Andrea Vavassori; Marcello Benassi; Roberto Orecchia; Marco Salvatore
Journal:  J Appl Clin Med Phys       Date:  2013-03-04       Impact factor: 2.102

9.  Monte Carlo study of a new I-125 brachytherapy prototype seed with a ceramic radionuclide carrier and radiographic marker.

Authors:  Lucas Paixão; Alessandro Facure; Ana Maria M Santos; Adriano Márcio dos Santos; Suely Epsztein Grynberg
Journal:  J Appl Clin Med Phys       Date:  2012-05-10       Impact factor: 2.102

10.  Cost in perspective: direct assessment of American market acceptability of Co-60 in gynecologic high-dose-rate brachytherapy and contrast with experience abroad.

Authors:  Raymond B Mailhot Vega; David Barbee; Wesley Talcott; Tamara Duckworth; Bhartesh A Shah; Omar F Ishaq; Christina Small; Anamaria R Yeung; Carmen A Perez; Peter B Schiff; Ophira Ginsburg; William Small; May Abdel-Wahab; Gustavo Sarria Bardales; Matthew Harkenrider
Journal:  J Contemp Brachytherapy       Date:  2018-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.